Abstract
MicroRNAs (miRNAs) have gained a lot of interest as biomarkers and biotherapeutics in recent years. The discovery of miRNAs in circulation as recently as 2008, aided by rapid advances in high-throughput profiling techniques initiated an explosion of investigations dedicated to discovering circulating miRNAs as minimally invasive biomarkers. As miRNAs regulate many cellular processes, investigators are actively exploring their relevance in disease treatment by miRNA restoration. This chapter demonstrates an approach to discover miRNAs of biomarker and therapeutic potential by isolating miRNAs from cell lines, performing global miRNA profiling, investigating miRNA expression in clinical specimens and examining their therapeutic relevance by restoring miRNA expression using Lipofectamine in vitro.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Esquela-Kerscher A, Slack FJ (2006) Oncomirs—microRNAs with a role in cancer. Nat Rev Cancer 6(4):259–269. doi:10.1038/nrc1840
Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116(2):281–297. doi:S0092867404000455
Calin GA, Dumitru CD, Shimizu M et al (2002) Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 99(24):15524–15529. doi:10.1073/pnas.242606799
Miska EA (2005) How microRNAs control cell division, differentiation and death. Curr Opin Genet Dev 15(5):563–568. doi:10.1016/j.gde.2005.08.005
O’Brien K, Lowry MC, Corcoran C et al (2015) miR-134 in extracellular vesicles reduces triple-negative breast cancer aggression and increases drug sensitivity. Oncotarget 20;6(32):32774–89. doi: 10.18632/oncotarget.5192.t
Chen X, Ba Y, Ma L et al (2008) Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 18(10):997–1006. doi:10.1038/cr.2008.282
Valadi H, Ekström K, Bossios A et al (2007) Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9(6):654–659. doi:10.1038/ncb1596
Skog J, Würdinger T, van Rijn S et al (2008) Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol 10(12):1470–1476. doi:10.1038/ncb1800
Vickers KC, Palmisano BT, Shoucri BM et al (2011) MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol 13(4):423–433. doi:10.1038/ncb2210
Wang K, Zhang S, Weber J et al (2010) Export of microRNAs and microRNA-protective protein by mammalian cells. Nucleic Acids Res 38(20):7248–7259. doi:10.1093/nar/gkq601
Tuck MK, Chan DW, Chia D et al (2009) Standard operating procedures for serum and plasma collection: early detection research network consensus statement standard operating procedure integration working group. J Proteome Res 8(1):113–117. doi:10.1021/pr800545q
Farina NH, Wood ME, Perrapato SD et al (2014) Standardizing analysis of circulating microRNA: clinical and biological relevance. J Cell Biochem 115(5):805–811. doi:10.1002/jcb.24745
McLean CS, Mielke C, Cordova JM et al (2015) Gene and MicroRNA expression responses to exercise; relationship with insulin sensitivity. PLoS One 10(5), e0127089. doi:10.1371/journal.pone.0127089
Zhang L, Hou D, Chen X et al (2012) Exogenous plant MIR168a specifically targets mammalian LDLRAP1: evidence of cross-kingdom regulation by microRNA. Cell Res 22(1):107–126. doi:10.1038/cr.2011.158
Vucic EA, Thu KL, Pikor LA et al (2014) Smoking status impacts microRNA mediated prognosis and lung adenocarcinoma biology. BMC Cancer 14:778. doi:10.1186/1471-2407-14-778
Davis CJ, Bohnet SG, Meyerson JM et al (2007) Sleep loss changes microRNA levels in the brain: a possible mechanism for state-dependent translational regulation. Neurosci Lett 422(1):68–73. doi:10.1016/j.neulet.2007.06.005
Leidner RS, Li L, Thompson CL (2013) Dampening enthusiasm for circulating microRNA in breast cancer. PLoS One 8(3), e57841. doi:10.1371/journal.pone.0057841
Paola Tiberio MC, Valentina Angeloni, Maria Grazia Daidone, and Valentina Appierto (2015) Challenges in Using Circulating miRNAs as Cancer Biomarkers. BioMed research international 2015 (Article ID 731479):10 pages. doi:http://dx.doi.org/10.1155/2015/731479
Kang K, Peng X, Luo J et al (2012) Identification of circulating miRNA biomarkers based on global quantitative real-time PCR profiling. J Anim Sci Biotechnol 3(1):4. doi:10.1186/2049-1891-3-4
Jansson MD, Lund AH (2012) MicroRNA and cancer. Mol Oncol 6(6):590–610. doi:10.1016/j.molonc.2012.09.006
Eva van Rooij SK (2014) Development of microRNA therapeutics is coming of age. EMBO Mol Med 6(7):851–864. doi:10.15252/emmm.201100899
Mirna Therapeutics I A Multicenter Phase I Study of MRX34, MicroRNA miR-RX34 Liposomal Injection. https://www.clinicaltrials.gov/ct2/show/NCT01829971?term=mrx34&rank=1.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media New York
About this protocol
Cite this protocol
O’Brien, K. (2017). TaqMan Low Density Array: MicroRNA Profiling for Biomarker and Oncosuppressor Discovery. In: Rani, S. (eds) MicroRNA Profiling. Methods in Molecular Biology, vol 1509. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-6524-3_8
Download citation
DOI: https://doi.org/10.1007/978-1-4939-6524-3_8
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-6522-9
Online ISBN: 978-1-4939-6524-3
eBook Packages: Springer Protocols